<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>

    <title>
                    Medicine and Healthcare |
                            Media Room |
                        Newswire
            </title>
    <link>https://co.newswire.com/</link>
    <description>Latest news from Newswire</description>

    <atom:link href="https://www.newswire.com/newsroom/rss/medicine-and-healthcare"
        rel="self" type="application/rss+xml" />

                                    <item>
        <title>Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19</title>
                    <link>https://www.newswire.com/news/sant-canada-autorise-deux-vaccins-arnm-de-moderna-un-vaccin-contre-la-grippe-et</link>
            <guid>https://www.newswire.com/news/sant-canada-autorise-deux-vaccins-arnm-de-moderna-un-vaccin-contre-la-grippe-et</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Le Canada est le premier pays &amp;agrave; autoriser &amp;agrave; la fois le vaccin &amp;agrave; ARNm de Moderna contre la grippe saisonni&amp;egrave;re, mFLUSIVA&lt;sup&gt;&amp;reg;&lt;/sup&gt;, et son vaccin combin&amp;eacute; contre la grippe et la COVID-19, mCOFLU&lt;sup&gt;&amp;reg;&lt;/sup&gt;&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 05 Nov 2026 22:55:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Health Canada Authorizes Moderna&#039;s mRNA Influenza and Combination Influenza and COVID-19 Vaccines</title>
                    <link>https://www.newswire.com/news/health-canada-authorizes-modernas-mrna-influenza-and-combination-influenza-and</link>
            <guid>https://www.newswire.com/news/health-canada-authorizes-modernas-mrna-influenza-and-combination-influenza-and</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Canada becomes the first country to authorize both Moderna&#039;s mRNA seasonal influenza vaccine, mFLUSIVA&lt;sup&gt;&amp;reg;&lt;/sup&gt;, and combination influenza and COVID-19 vaccine, mCOFLU&lt;sup&gt;&amp;reg;&lt;/sup&gt;&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 05 Nov 2026 22:20:00 +0000</pubDate>
    </item>
                                                <item>
        <title>CV Sciences, Inc. To Announce Third Quarter 2026 Results On November 12, 2026</title>
                    <link>https://www.newswire.com/news/cv-sciences-inc-to-announce-third-quarter-2026-results-on-november-12-2026</link>
            <guid>https://www.newswire.com/news/cv-sciences-inc-to-announce-third-quarter-2026-results-on-november-12-2026</guid>
                <description></description>
        <pubDate>Thu, 05 Nov 2026 22:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Protagonist Reports Third Quarter 2026 Financial Results and Provides Corporate Update</title>
                    <link>https://www.newswire.com/news/protagonist-reports-third-quarter-2026-financial-results-and-provides-corporate</link>
            <guid>https://www.newswire.com/news/protagonist-reports-third-quarter-2026-financial-results-and-provides-corporate</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;MIMRYLO&amp;trade; (rusfertide) Approved by FDA for the Treatment of Erythrocytosis in Adults with Polycythemia Vera; Approval Triggered $275 Million in Payments to Protagonist&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;&lt;strong&gt;Comprehensive Phase 2b Program with PN-881, an Oral IL-17 Antagonist for Psoriasis, Planned to Initiate in Early Q1 2027&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;&lt;strong&gt;$300 Million Share Repurchase Program Announced in September 2026&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;&lt;strong&gt;Cash, Cash Equivalents and Marketable Securities of $834.6 Million as of September 30, 2026&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 05 Nov 2026 21:05:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Colombia&#039;s Poultry Industry Is Growing; Layered Biosecurity Can Help Sustain that Growth</title>
                    <link>https://www.newswire.com/news/colombias-poultry-industry-is-growing-layered-biosecurity-can-help-sustain-that</link>
            <guid>https://www.newswire.com/news/colombias-poultry-industry-is-growing-layered-biosecurity-can-help-sustain-that</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Synexis and Representaciones Guma collaborate to bring continuous indoor pathogen control to producers across Colombia.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 05 Nov 2026 15:45:00 +0000</pubDate>
    </item>
                                                <item>
        <title>IGC Pharma&#039;s Alzheimer&#039;s Agitation Drug Candidate Now Patented in the U.S., Canada, and Mexico as Phase 2 Readout Nears</title>
                    <link>https://www.newswire.com/news/igc-pharmas-alzheimers-agitation-drug-candidate-now-patented-in-the-u-s-canada</link>
            <guid>https://www.newswire.com/news/igc-pharmas-alzheimers-agitation-drug-candidate-now-patented-in-the-u-s-canada</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Canada grants patent on IGC-AD1, an investigational oral therapy for agitation in Alzheimer&#039;s disease. Agitation is one of the hardest symptoms for families to manage.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 05 Nov 2026 15:18:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Who Is the Best Facial Feminization Surgeon in the US?</title>
                    <link>https://www.newswire.com/news/who-is-the-best-facial-feminization-surgeon-in-the-us-22885105</link>
            <guid>https://www.newswire.com/news/who-is-the-best-facial-feminization-surgeon-in-the-us-22885105</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;The Best FFS Surgeon in the U.S. is Dr. Javad Sajan&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 05 Nov 2026 15:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>VSee Health Announces 13 New Hospital Agreements Expected to Generate More Than $3 Million in Annual Revenue</title>
                    <link>https://www.newswire.com/news/vsee-health-announces-13-new-hospital-agreements-expected-to-generate-more-than</link>
            <guid>https://www.newswire.com/news/vsee-health-announces-13-new-hospital-agreements-expected-to-generate-more-than</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Multi-year agreements expand iDoc subsidiary&#039;s delivery of tele-ICU services and teleradiology platform solutions&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 05 Nov 2026 14:30:00 +0000</pubDate>
    </item>
                                                <item>
        <title>From Images to Data: Ten Years on, Tribun Health Opens a New Chapter in Digital Pathology</title>
                    <link>https://www.newswire.com/news/from-images-to-data-ten-years-on-tribun-health-opens-a-new-chapter-in-digital</link>
            <guid>https://www.newswire.com/news/from-images-to-data-ten-years-on-tribun-health-opens-a-new-chapter-in-digital</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;The French company aims to bring images, reports, data and artificial intelligence together on one platform and accelerate its international growth.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 05 Nov 2026 14:25:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Sharma Oral Surgery Urges Charlotte-Area Families to Consider Wisdom Tooth Evaluation Before Age 25</title>
                    <link>https://www.newswire.com/news/sharma-oral-surgery-urges-charlotte-area-families-to-consider-wisdom-tooth</link>
            <guid>https://www.newswire.com/news/sharma-oral-surgery-urges-charlotte-area-families-to-consider-wisdom-tooth</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Board-certified oral surgeons explain why early assessment matters, and what local patients and referring dentists should know about timing, risks, and recovery.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 05 Nov 2026 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Aptevo Achieves Key Clinical Development Objective, Significantly Reducing Infusion-Related Reactions with Mipletamig in Frontline AML</title>
                    <link>https://www.newswire.com/news/aptevo-achieves-key-clinical-development-objective-significantly-reducing</link>
            <guid>https://www.newswire.com/news/aptevo-achieves-key-clinical-development-objective-significantly-reducing</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Refined priming-dose regimen addresses important treatment-tolerability objective identified through FDA discussions, further strengthening mipletamig&#039;s readiness for Phase 2 development&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;&lt;strong&gt;Substantial reduction in infusion reaction frequency and severity improves the patient treatment experience without compromising planned therapeutic dosing&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;&lt;strong&gt;Achievement builds on mipletamig&#039;s encouraging clinical activity and favorable safety profile as a potential addition to the current standard of care&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 05 Nov 2026 13:30:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Dermata Therapeutics Highlights Media Recognition of Tome Skincare Following Commercial Launch</title>
                    <link>https://www.newswire.com/news/dermata-therapeutics-highlights-growing-media-recognition-of-tome-22885076</link>
            <guid>https://www.newswire.com/news/dermata-therapeutics-highlights-growing-media-recognition-of-tome-22885076</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;- Tome Skincare featured in Cosmopolitan, Women&#039;s Wear Daily, AIR MAIL, and Thingtesting highlights Tome&#039;s growing recognition among leading beauty editors -&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 05 Nov 2026 13:30:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Cosmos Health&#039;s CosmoFarm Begins Commissioning New Automated Order-Processing and Vehicle-Loading Infrastructure, Advancing Capacity That Could Support Over $120 Million in Annual Revenue</title>
                    <link>https://www.newswire.com/news/see-1614862</link>
            <guid>https://www.newswire.com/news/see-1614862</guid>
                <description>&lt;ul&gt;&lt;li&gt;&lt;strong&gt;New order-processing line: &lt;/strong&gt;automated handling cell and roller conveyor now being commissioned at CosmoFarm&#039;s distribution center in Peristeri, Athens, designed to move more orders through the facility in less time&lt;/li&gt;&lt;li&gt;&lt;strong&gt;New vehicle-loading lanes: &lt;/strong&gt;multiple rows of roller flow lanes designed to significantly reduce the time needed to load each delivery vehicle&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Earlier dispatch: &lt;/strong&gt;faster processing and loading are expected to get vehicles on the road sooner, supporting earlier pharmacy deliveries and capacity for additional routes&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Acquisition pipeline: &lt;/strong&gt;CosmoFarm has an active letter of intent to acquire a network with approximately &amp;euro;10 million (approximately $11.3 million) in annual gross revenue, which, if completed, would be its largest acquisition to date&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Ongoing automation program: &lt;/strong&gt;the new infrastructure is part of CosmoFarm&#039;s multi-year program in robotics, automation and artificial intelligence&lt;/li&gt;&lt;/ul&gt;</description>
        <pubDate>Thu, 05 Nov 2026 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>BioAdaptives to Acquire Xycota Biosciences to Pursue the Potential of At Home Psilocybin Treatment</title>
                    <link>https://www.newswire.com/news/bioadaptives-to-acquire-xycota-biosciences-to-pursue-the-potential-of-at-home</link>
            <guid>https://www.newswire.com/news/bioadaptives-to-acquire-xycota-biosciences-to-pursue-the-potential-of-at-home</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Xycota&#039;s lead program aims to deliver clinical benefit from low-dose psilocybin without hallucinogenic effects, with mild PTSD as its initial target.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 05 Nov 2026 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Former DEA Administrator Sounds Alarm on Drug Safety as Federal Marijuana Rescheduling Faces Critical November 5 Deadline</title>
                    <link>https://www.newswire.com/news/former-dea-administrator-sounds-alarm-on-drug-safety-as-federal-marijuana</link>
            <guid>https://www.newswire.com/news/former-dea-administrator-sounds-alarm-on-drug-safety-as-federal-marijuana</guid>
                <description>&lt;p&gt;&lt;a rel=&quot;nofollow&quot; href=&quot;https://www.washingtontimes.com/news/2026/nov/4/reagans-drug-policy-still-matters/&quot;&gt;&lt;i&gt;&lt;strong&gt;Duane Boise CEO MMJ International Holdings Points to Warnings from Former DEA Administrator Asa Hutchinson, the American Medical Association and GAO as Federal Courts Review Challenges to Marijuana Policy&lt;/strong&gt;&lt;/i&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;&lt;strong&gt;MMJ&#039;s CMS Beneficiary Incentive Case Is on Appeal Before the U.S. Court of Appeals for the D.C. Circuit&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 05 Nov 2026 02:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Emerging Growth Research Reports Continued Revenue Growth at Immuron</title>
                    <link>https://www.newswire.com/news/emerging-growth-research-reports-continued-revenue-growth-at-immuron</link>
            <guid>https://www.newswire.com/news/emerging-growth-research-reports-continued-revenue-growth-at-immuron</guid>
                <description></description>
        <pubDate>Wed, 04 Nov 2026 23:10:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Payer Outsourcing Enters a Reset as AI Rewrites Health Plan Economics, Black Book finds</title>
                    <link>https://www.newswire.com/news/payer-outsourcing-enters-a-reset-as-ai-rewrites-health-plan-economics-22884930</link>
            <guid>https://www.newswire.com/news/payer-outsourcing-enters-a-reset-as-ai-rewrites-health-plan-economics-22884930</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;New 2027 outlook finds payer leaders reassessing outsourcing, offshoring, nearshoring and insourcing as automation, interoperability mandates and rising administrative expense redefine the economics of managed care&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 04 Nov 2026 21:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Elevate Healthcare Introduces OpSpace, the Operations Mission Control for Healthcare Simulation</title>
                    <link>https://www.newswire.com/news/elevate-healthcare-introduces-opspace-the-operations-mission-control-22884949</link>
            <guid>https://www.newswire.com/news/elevate-healthcare-introduces-opspace-the-operations-mission-control-22884949</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;The world needs more healthcare professionals. OpSpace gives educators more capacity to prepare them.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 04 Nov 2026 20:30:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Midterm 2026 Healthcare Ballot Results and Impacts Across 13 States: Black Book Research Follow-Up</title>
                    <link>https://www.newswire.com/news/midterm-2026-healthcare-ballot-results-and-impacts-across-13-states-22884913</link>
            <guid>https://www.newswire.com/news/midterm-2026-healthcare-ballot-results-and-impacts-across-13-states-22884913</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Voters preserve Medicaid expansion and reject California&#039;s clinic spending mandate as Black Book&#039;s day-after-election update to its pre-election study examines projected results, current vote leaders and implications for healthcare providers and payers across 13 states, based on the latest counts&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 04 Nov 2026 16:10:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study</title>
                    <link>https://www.newswire.com/news/copy-moderna-advances-investigational-bundibugyo-ebolavirus-vaccine-toward</link>
            <guid>https://www.newswire.com/news/copy-moderna-advances-investigational-bundibugyo-ebolavirus-vaccine-toward</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;WHO Technical Advisory Group recommends mRNA-1469 for inclusion in efficacy study following encouraging Phase 1 clinical results&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 04 Nov 2026 16:05:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual Meeting</title>
                    <link>https://www.newswire.com/news/moderna-announces-oral-presentation-of-mrna-2808-clinical-data-at-2026-american</link>
            <guid>https://www.newswire.com/news/moderna-announces-oral-presentation-of-mrna-2808-clinical-data-at-2026-american</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Initial Phase 1/2 data highlight the potential of Moderna&#039;s multiplexed mRNA approach in relapsed or refractory multiple myeloma&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 04 Nov 2026 14:50:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Cosmos Health&#039;s Amazon UK Business Surpasses $2 Million in TTM Sales, Up 90%, with a 23% Net Profit Margin; Expects Sales to Grow Approximately 72% to $3.9 Million Over the Next Twelve Months</title>
                    <link>https://www.newswire.com/news/see-6538010</link>
            <guid>https://www.newswire.com/news/see-6538010</guid>
                <description>&lt;ul&gt;&lt;li&gt;&lt;i&gt;&lt;strong&gt;Amazon UK sales up 90%:&lt;/strong&gt; $2.27 million in TTM sales for the twelve months to November 2, 2026, up from approximately $1.19 million in the prior twelve months&lt;/i&gt;&lt;/li&gt;&lt;li&gt;&lt;i&gt;&lt;strong&gt;23% net margin on Amazon UK:&lt;/strong&gt; the Amazon UK channel generated $525,000 in net profit after all direct channel costs, including Amazon fees, cost of goods, shipping, advertising and VAT&lt;/i&gt;&lt;/li&gt;&lt;li&gt;&lt;i&gt;&lt;strong&gt;116,978 units sold on Amazon UK:&lt;/strong&gt; an average of approximately 320 units per day&lt;/i&gt;&lt;/li&gt;&lt;li&gt;&lt;i&gt;&lt;strong&gt;Record performance:&lt;/strong&gt; July through October 2026 were the four strongest months to date on Amazon UK, each with sales above $215,000&lt;/i&gt;&lt;/li&gt;&lt;li&gt;&lt;i&gt;&lt;strong&gt;Efficient growth:&lt;/strong&gt; advertising costs of only 2.4% of Amazon UK sales, with refunds below 1%&lt;/i&gt;&lt;/li&gt;&lt;li&gt;&lt;i&gt;&lt;strong&gt;72% growth expected:&lt;/strong&gt; the Company expects Amazon UK sales of approximately $3.9 million over the next twelve months, an average of approximately $325,000 per month&lt;/i&gt;&lt;/li&gt;&lt;/ul&gt;</description>
        <pubDate>Wed, 04 Nov 2026 14:27:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Medical Care Technologies Inc. (OTCID:MDCE) Moves $250,000 Software Agreement Into Active Development</title>
                    <link>https://www.newswire.com/news/medical-care-technologies-inc-otcid-mdce-moves-250-000-software-agreement-into</link>
            <guid>https://www.newswire.com/news/medical-care-technologies-inc-otcid-mdce-moves-250-000-software-agreement-into</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Development Underway on Integrated Web Front-End and Custom Enterprise Backend Covering Inventory, Sales, and Ongoing Technical Support&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 04 Nov 2026 13:57:00 +0000</pubDate>
    </item>
                                                <item>
        <title>TriageLogic&#039;s MedMessage Automate Frees Up Over 37 Hours of Staff Time in the First Three Business Days</title>
                    <link>https://www.newswire.com/news/triagelogics-medmessage-automate-frees-up-over-37-hours-of-staff-time-in-the</link>
            <guid>https://www.newswire.com/news/triagelogics-medmessage-automate-frees-up-over-37-hours-of-staff-time-in-the</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Nurse triage software processes 749 patient messages for a 25-physician group across 10 locations after a simple triage phone nurse workflow upgrade.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 04 Nov 2026 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>5 Benefits of Remote Patient Monitoring (RPM) for Patients and Healthcare Providers</title>
                    <link>https://www.newswire.com/news/5-benefits-of-remote-patient-monitoring-rpm-for-patients-and-healthcare</link>
            <guid>https://www.newswire.com/news/5-benefits-of-remote-patient-monitoring-rpm-for-patients-and-healthcare</guid>
                <description>Discover five RPM benefits, including earlier intervention, better chronic disease management, patient engagement, and improved care coordination.</description>
        <pubDate>Tue, 03 Nov 2026 17:40:00 +0000</pubDate>
    </item>
                                                <item>
        <title>VRCCO Unveils 2027 Continuing Education Lineup with Expanded Offerings and Dedicated Team Tracks</title>
                    <link>https://www.newswire.com/news/vrcco-unveils-2027-continuing-education-lineup-with-expanded-offerings-22880967</link>
            <guid>https://www.newswire.com/news/vrcco-unveils-2027-continuing-education-lineup-with-expanded-offerings-22880967</guid>
                <description></description>
        <pubDate>Tue, 03 Nov 2026 17:25:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Nature&#039;s Answer(R) Expands Its Fast-Growing Mullein-X(R) Line with the Launch of New Daily Gummies</title>
                    <link>https://www.newswire.com/news/nature-s-answer-expands-its-fast-growing-mullein-x-line-with-the-22880217</link>
            <guid>https://www.newswire.com/news/nature-s-answer-expands-its-fast-growing-mullein-x-line-with-the-22880217</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;New cleaner, sugar-free, plant-based gummies deliver 2,000 mg of organic mullein per serving, with no artificial flavors or colors, offering a convenient and delicious way to support daily respiratory wellness.*&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 03 Nov 2026 17:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Rush University System for Health Selects AGFA HealthCare&#039;s Enterprise Imaging Cloud</title>
                    <link>https://www.newswire.com/news/rush-university-system-for-health-selects-agfa-healthcare-s-enterprise-imaging</link>
            <guid>https://www.newswire.com/news/rush-university-system-for-health-selects-agfa-healthcare-s-enterprise-imaging</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Leading academic health system will unify enterprise imaging across radiology, cardiology, and other clinical specialties on a single cloud platform.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 03 Nov 2026 15:35:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Brooke Carrero, RN, BSN, Hosts Advanced Aesthetic Injector Training at Becker Aesthetics &amp; Plastic Surgery</title>
                    <link>https://www.newswire.com/news/brooke-carrero-rn-bsn-hosts-advanced-aesthetic-injector-training-at-22877467</link>
            <guid>https://www.newswire.com/news/brooke-carrero-rn-bsn-hosts-advanced-aesthetic-injector-training-at-22877467</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Philadelphia aesthetic nurse injector leads an intimate, observation-based training for visiting injectors, with quarterly sessions planned and the next registration opening in February 2027.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 03 Nov 2026 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>SHI Advanced Technologies Turns Published Research into an Interactive Customer Resource with Bioz</title>
                    <link>https://www.newswire.com/news/shi-advanced-technologies-turns-published-research-into-an-interactive-customer</link>
            <guid>https://www.newswire.com/news/shi-advanced-technologies-turns-published-research-into-an-interactive-customer</guid>
                <description></description>
        <pubDate>Tue, 03 Nov 2026 09:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Impact Biomedical Inc. and Zoar Limited Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination</title>
                    <link>https://www.newswire.com/news/impact-biomedical-inc-and-zoar-limited-announce-sec-declaration-of</link>
            <guid>https://www.newswire.com/news/impact-biomedical-inc-and-zoar-limited-announce-sec-declaration-of</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Special meeting of Impact Biomedical stockholders to approve the proposed Business Combination scheduled for November 13, 2026, at 10:00 a.m. Eastern Standard Time&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;&lt;strong&gt;Upon closing, the combined company is expected to operate as Zoar Limited and trade on NYSE American under the ticker symbol &quot;ZOAR,&quot; subject to listing approval&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 03 Nov 2026 04:25:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Family Hospice Care Celebrates 20 Years of Light, Love and Legacy During National Home Health Month and Hospice and Palliative Care Month</title>
                    <link>https://www.newswire.com/news/family-hospice-care-celebrates-20-years-of-light-love-and-legacy-during</link>
            <guid>https://www.newswire.com/news/family-hospice-care-celebrates-20-years-of-light-love-and-legacy-during</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;20th anniversary celebration will honor two decades of compassionate end-of-life care and the patients, families and professionals who have shaped the organization&#039;s legacy&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 02 Nov 2026 17:50:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Suncoast Skin Solutions Surpasses 48,000 Five-Star Patient Reviews</title>
                    <link>https://www.newswire.com/news/suncoast-skin-solutions-surpasses-48-000-five-star-patient-reviews-22880936</link>
            <guid>https://www.newswire.com/news/suncoast-skin-solutions-surpasses-48-000-five-star-patient-reviews-22880936</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Florida dermatology practice reaches milestone across more than 40 locations&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 02 Nov 2026 17:45:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Marijuana Rescheduling In Peril: AMA Demands FDA Scientific Standards As GAO Report Exposes Malaise</title>
                    <link>https://www.newswire.com/news/marijuana-rescheduling-in-peril-ama-demands-fda-scientific-standards-as-gao</link>
            <guid>https://www.newswire.com/news/marijuana-rescheduling-in-peril-ama-demands-fda-scientific-standards-as-gao</guid>
                <description>&lt;p&gt;&lt;strong&gt;MMJ International Holdings CEO Duane Boise Says &quot;&lt;/strong&gt;&lt;a rel=&quot;nofollow&quot; href=&quot;https://www.ama-assn.org/press-center/ama-press-releases/ama-urges-fda-pursue-safety-standards-botanical-products&quot;&gt;&lt;strong&gt;The American Medical Association October 28 Letter &lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;and &lt;/strong&gt;&lt;a rel=&quot;nofollow&quot; href=&quot;https://www.ama-assn.org/press-center/ama-press-releases/ama-urges-fda-pursue-safety-standards-botanical-products&quot;&gt;&lt;strong&gt;Congressional Watchdog&#039;s GAO Findings &lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;Raise Fundamental Questions About Federal rescheduling and Authorization of Non-FDA-Approved Marijuana Products&quot;.&lt;/strong&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 02 Nov 2026 16:30:00 +0000</pubDate>
    </item>
                                                <item>
        <title>OSR Health Board Authorizes Management to Engage with Potential Acquirer of OSRK for Reverse Takeover</title>
                    <link>https://www.newswire.com/news/osr-health-board-authorizes-management-to-engage-with-potential-acquirer-of</link>
            <guid>https://www.newswire.com/news/osr-health-board-authorizes-management-to-engage-with-potential-acquirer-of</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Potential reverse takeover is a key pillar of plan to return portfolio to a national exchange; OSR Health also pursuing OTCQB uplisting&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 02 Nov 2026 16:05:00 +0000</pubDate>
    </item>
                                                <item>
        <title>QuickMD Names Omar Manejwala, M.D. as Chief Medical Officer</title>
                    <link>https://www.newswire.com/news/quickmd-names-omar-manejwala-m-d-as-chief-medical-officer</link>
            <guid>https://www.newswire.com/news/quickmd-names-omar-manejwala-m-d-as-chief-medical-officer</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Nationally recognized addiction psychiatrist, former DarioHealth and Catasys CMO, and author joins the largest U.S. telemedicine provider of opioid use disorder care&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 02 Nov 2026 15:30:00 +0000</pubDate>
    </item>
                                                <item>
        <title>CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)</title>
                    <link>https://www.newswire.com/news/cso-of-napo-pharmaceuticals-a-jaguar-health-family-company-and-clinical</link>
            <guid>https://www.newswire.com/news/cso-of-napo-pharmaceuticals-a-jaguar-health-family-company-and-clinical</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and short bowel syndrome (SBS-IF) for crofelemer powder for oral solution, targeting an NDA filing for MVID mid-2027&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 02 Nov 2026 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Dr. Carlos Sanchez Speaks on Structural Heart Disease at TCT 2026</title>
                    <link>https://www.newswire.com/news/dr-carlos-sanchez-speaks-on-structural-heart-disease-at-tct-2026</link>
            <guid>https://www.newswire.com/news/dr-carlos-sanchez-speaks-on-structural-heart-disease-at-tct-2026</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Interventional cardiologist contributes to four TCT 2026 sessions in San Diego as a speaker, panelist, and discussant, sharing his heart team&#039;s experience in structural heart disease with physicians from around the world.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 02 Nov 2026 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Medical Care Technologies Inc. (OTCID:MDCE) Delivers Stronger Melanoma Scan Beta Readout on Expanded Human-Submitted Dataset</title>
                    <link>https://www.newswire.com/news/medical-care-technologies-inc-otcid-mdce-delivers-stronger-melanoma-scan-beta</link>
            <guid>https://www.newswire.com/news/medical-care-technologies-inc-otcid-mdce-delivers-stronger-melanoma-scan-beta</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Expanded Human-Submitted Image Review Shows Image-Quality Pass Rate of 86%, Body-Map Registration of 89% and Change-Over-Time Alignment of 91%&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 02 Nov 2026 13:57:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Vicapsys Life Sciences Provides Shareholder Update on VICAPSYN(TM) Program Advancing Toward Phase 1 Human Clinical Trial, Vertically Integrated With the Company&#039;s Indian Health Service Strategy</title>
                    <link>https://www.newswire.com/news/vicapsys-life-sciences-provides-shareholder-update-on-vicapsyn-program</link>
            <guid>https://www.newswire.com/news/vicapsys-life-sciences-provides-shareholder-update-on-vicapsyn-program</guid>
                <description>&lt;ul&gt;&lt;li&gt;&lt;i&gt;&lt;strong&gt;VICAPSYN&lt;sup&gt;&amp;trade;&lt;/sup&gt;, the Company&#039;s immune-isolation technology for islet cell transplantation in type 1 diabetes, remains an active asset of Vicapsys and is being carried forward under the Company&#039;s new operating structure&lt;/strong&gt;&lt;/i&gt;&lt;/li&gt;&lt;li&gt;&lt;i&gt;&lt;strong&gt;Strategy integrates the program with the Company&#039;s tribal and federal health channel, including the Indian Health Service network, from clinical development through delivery&lt;/strong&gt;&lt;/i&gt;&lt;/li&gt;&lt;li&gt;&lt;i&gt;&lt;strong&gt;Preclinical proof-of-concept work advancing toward a Phase 1 human clinical trial&lt;/strong&gt;&lt;/i&gt;&lt;/li&gt;&lt;li&gt;&lt;i&gt;&lt;strong&gt;Company exploring partnerships in Argentina that could establish an international arm and a Latin American licensing opportunity alongside its U.S. program&lt;/strong&gt;&lt;/i&gt;&lt;/li&gt;&lt;li&gt;&lt;i&gt;&lt;strong&gt;Vertex Pharmaceuticals&#039; $950 million acquisition of Semma Therapeutics, and clinical results that still require chronic immunosuppression, underscore both the value of islet cell therapy and the problem VICAPSYN&lt;sup&gt;&amp;trade; &lt;/sup&gt;is designed to solve&lt;/strong&gt;&lt;/i&gt;&lt;/li&gt;&lt;/ul&gt;</description>
        <pubDate>Mon, 02 Nov 2026 13:30:00 +0000</pubDate>
    </item>
                                                <item>
        <title>cbdMD Completes Acquisition of the Operating Assets and Brands of Twinlab, including Twinlab, Reserveage and Metabolife Brands, Expanding Into Broader Wellness</title>
                    <link>https://www.newswire.com/news/cbdmd-completes-acquisition-of-the-operating-assets-and-brands-of-twinlab</link>
            <guid>https://www.newswire.com/news/cbdmd-completes-acquisition-of-the-operating-assets-and-brands-of-twinlab</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Iconic supplement brands join cbdMD&#039;s portfolio, diversifying the company beyond hemp and positioning it &quot;from the fundamentals to the frontier of wellness&quot;&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 02 Nov 2026 13:11:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Ohio Emergency Medicine Services to Lead Emergency Department at Hocking Valley Community Hospital</title>
                    <link>https://www.newswire.com/news/ohio-emergency-medicine-services-to-lead-emergency-department-at-hocking-valley</link>
            <guid>https://www.newswire.com/news/ohio-emergency-medicine-services-to-lead-emergency-department-at-hocking-valley</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Physician-led group expands its presence in Southeast Ohio, beginning emergency department management in Logan on November 1, 2026&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 02 Nov 2026 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Hospital AI Funding Faces a Reality Check: New 2027 Outlook Puts Outsourcing Savings to the Test</title>
                    <link>https://www.newswire.com/news/hospital-ai-funding-faces-a-reality-check-new-2027-outlook-puts-22880483</link>
            <guid>https://www.newswire.com/news/hospital-ai-funding-faces-a-reality-check-new-2027-outlook-puts-22880483</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Black Book&#039;s 94-page report examines how hospital boards, CIOs and CFOs can turn operating changes into sustainable AI funding while protecting patients, staff and essential services.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 02 Nov 2026 11:30:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Glioblastoma Foundation&#039;s Genomic Testing &amp; Research Laboratory Now Accepting Patient Samples for Genomic Testing</title>
                    <link>https://www.newswire.com/news/glioblastoma-foundation-s-genomic-testing-research-laboratory-now-22880316</link>
            <guid>https://www.newswire.com/news/glioblastoma-foundation-s-genomic-testing-research-laboratory-now-22880316</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;The Foundation&#039;s CLIA-certified laboratory combines DNA methylation profiling, MGMT status, copy-number variation analysis and glioblastoma subtype characterization in a single assay&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Sat, 31 Oct 2026 15:55:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Villora Reviews and Complaints 2026: No Scoops, No Mixing-Is This Your Next Daily Gut Routine?</title>
                    <link>https://www.newswire.com/news/villora-reviews-and-complaints-2026-no-scoops-no-mixing-is-this-your-next-daily</link>
            <guid>https://www.newswire.com/news/villora-reviews-and-complaints-2026-no-scoops-no-mixing-is-this-your-next-daily</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Villora&#039;s once-daily capsule offers a simple format for adults exploring digestive wellness support. This review examines the brand-stated fiber-and-probiotic blend, package options, and purchase details to help readers assess whether it fits their routine.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Sat, 31 Oct 2026 01:05:00 +0000</pubDate>
    </item>
                                                <item>
        <title>CORRECTION: Dr. Feliciano Serrano Connects Kidney Care with Clear Communication for Los Angeles Families</title>
                    <link>https://www.newswire.com/news/dr-feliciano-serrano-connects-kidney-care-with-clear-communication-for-los</link>
            <guid>https://www.newswire.com/news/dr-feliciano-serrano-connects-kidney-care-with-clear-communication-for-los</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;This release corrects and replaces the previous release disseminated Thursday, 29 October 2026 at 07:08 PM ET with an incorrect image.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;&lt;strong&gt;Please see the corrected release below.&amp;nbsp;&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;&lt;strong&gt;A closer look at bilingual patient education, specialist preparation, research, and the community background of a Huntington Park physician.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Fri, 30 Oct 2026 23:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Dr. Sheenso Lymphatic Drainage Drops Reviews and Complaints 2026: Could This Herbal Routine Fit Your Day?</title>
                    <link>https://www.newswire.com/news/dr-sheenso-lymphatic-drainage-drops-reviews-and-complaints-2026-could-this</link>
            <guid>https://www.newswire.com/news/dr-sheenso-lymphatic-drainage-drops-reviews-and-complaints-2026-could-this</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;For buyers drawn to a liquid herbal supplement, this review examines Dr. Sheenso&#039;s four brand-listed botanicals, advertised daily routine, package pricing, and purchase considerations before ordering.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Fri, 30 Oct 2026 21:30:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split</title>
                    <link>https://www.newswire.com/news/bluejay-diagnostics-announces-1-for-4-reverse-stock-split</link>
            <guid>https://www.newswire.com/news/bluejay-diagnostics-announces-1-for-4-reverse-stock-split</guid>
                <description></description>
        <pubDate>Fri, 30 Oct 2026 14:30:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Restoring Volume, Stimulating Collagen: BODYWELLE&#039;s Dr. Alonso Martin Discusses Sculptra and Radiesse</title>
                    <link>https://www.newswire.com/news/restoring-volume-stimulating-collagen-bodywelle-s-dr-alonso-martin-22875382</link>
            <guid>https://www.newswire.com/news/restoring-volume-stimulating-collagen-bodywelle-s-dr-alonso-martin-22875382</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;The Miami Beach physician explains how collagen biostimulators differ from traditional fillers and why results with these treatments build gradually over time.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Fri, 30 Oct 2026 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Surmodics Launches MetalPro(TM) Direct-to-Metal Hydrophilic Coatings for Medical Devices</title>
                    <link>https://www.newswire.com/news/surmodics-launches-metalpro-direct-to-metal-hydrophilic-coatings-for-medical</link>
            <guid>https://www.newswire.com/news/surmodics-launches-metalpro-direct-to-metal-hydrophilic-coatings-for-medical</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;High-performance hydrophilic coatings bond directly to metal surfaces without primers or tie-coats, simplifying manufacturing and expanding design flexibility.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Fri, 30 Oct 2026 13:37:00 +0000</pubDate>
    </item>
                        
</channel>
</rss>
